Literature DB >> 32888447

Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy.

Audrey A Tran1, Vinay Prasad2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32888447     DOI： 10.1016/S1470-2045(20)30424-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET.

Authors:  Tereza Buchtova; Zdenek Skrott; Katarina Chroma; Jiri Rehulka; Petr Dzubak; Marian Hajduch; David Lukac; Stefanos Arampatzis; Jiri Bartek; Martin Mistrik
Journal:  Mol Oncol       Date:  2021-10-26       Impact factor: 6.603

Review 2.  Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.

Authors:  Xiao-Yu Li; Ya-Nan Pi; Yao Chen; Qi Zhu; Bai-Rong Xia
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

Review 3.  Metabolic Drivers of Invasion in Glioblastoma.

Authors:  Joseph H Garcia; Saket Jain; Manish K Aghi
Journal:  Front Cell Dev Biol       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.